A Multi-center Clinical Study of Drug Antibody and Precision Transfusion in China

NCT05606302 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 14000

Last updated 2022-11-04

No results posted yet for this study

Summary

Blood samples for hemolytic anemia in patients treated with one or more of the antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin were screened for the production of drug antibodies.

Conditions

  • Drug-specific Antibodies

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05606302 on ClinicalTrials.gov